Skip to content
FIND A HEALTH VALLEY ACTOR

Autonomyo Raises CHF 1.4 M for its Skywalk Device and Starts a Crowdfunding

Autonomyo

Swiss medical technology company Autonomyo launches a CHF 550,000 crowdfunding campaign to supplement the CHF 1.4 Million already raised, in order to put Skywalk, a revolutionary rehabilitation device, on the market. Every two seconds, someone in the world suffers a stroke. Every year, 15 million people are affected, and half of them never fully regain…

Read More

Perivision Gets the Startup Nights Healthtech Award

Perivision Startup Nights

PeriVision SA, a Swiss medtech and AI spin-off from the University of Bern, with offices at Biopôle, is re-imagining eye testing. The startup won 1st place in the HealthTech Award and 1st place in the Final Public Award at Startup Nights. PeriVision’s eye testing platform, VisionOne, combines commercial VR headsets with advanced AI algorithms to…

Read More

SmartHear and Needless Join CSEM Accelerate Programme

CSEM - Accelerate

The CSEM has selected two life sciences projects its ACCELERATE 2025 programme — an initiative designed to help transform deep-tech innovations into real-world, market-ready solutions. SmartHear – Training the Brain to Listen BetterL’avenir de l’audition se joue dans le cerveau SmartHear is developing a next-generation neurotechnology platform that bridges auditory science and cognitive health. Using…

Read More

Healio Supported by FIT

Helio

Healio, a collaborative app for efficient healthcare staff scheduling has been awarded a CHF 20,000 Digital Grant from the Foundation for Innovation Technologique (FIT) In the healthcare sector, team scheduling is a complex process that can be a source of dissatisfaction and is subject to several constraints, including operational needs, legal labour regulations and individual…

Read More

BioAlps Academy Award Goes to Professor Pierre Magistretti

BND 2025 - Magistretti OK

On 11 November 2025, during the BioAlps Networking Day, the BioAlps Academy Award — the highest academic distinction granted by the Health Valley ecosystem — was presented to Professor Pierre Magistretti, one of the world’s leading figures in neuroscience. A physician, researcher and academic leader, he joins the select group of scientists who have left…

Read More

The BioAlps Industry Award 2025 Goes to Merck Group

BND 2025 - Merck

BioAlps Association is proud to announce that the 2025 BioAlps Industry Award has been presented to Merck Group in recognition of its exceptional contribution to the economic and scientific landscape of Western Switzerland. The Award was granted today in Monthey, during the BioAlps Networking Day, the flagship annual event of the Swiss Health Valley. Merck’s…

Read More

WEF – Technology Pioneer

Apply before 31 January 2026 for the Technology Pioneer Contest organised by the World Economic Forum The World Economic Forum’s Technology Pioneers community is composed of early-stage start-ups from around the world who are developing and deploying new technologies and innovations. Each year the Forum selects 100 companies to work with society’s foremost political, business and cultural…

Read More

ORION: A smart microfactory to accelerate personalized cancer treatments

ORION HE Arc

The watchmaking microfactory developed by Haute Ecole Arc Ingénierie has inspired ORION, a new research project bringing together 24 partners around personalized cancer treatments. ORION is one of four projects selected by the Swiss Federal Innovation Agency Innosuisse as part of its flagship initiative, “Artificial Intelligence in the Life Sciences, from a Human Health Perspective.”With…

Read More

Protonica Gets a CHF 400,000 Innosuisse Grant

Protonica

The EPFL spin-off announces a new Innosuisse grant of approximately CHF 400,000, awarded with strong support from EPFL and CSEM. Protonica is on a mission to transform cancer care by making proton therapy more precise, effective, and accessible. Unlike conventional radiotherapy, proton therapy can target tumors with high accuracy, limiting damage to healthy tissue and…

Read More

Oculis Raises $110 Million to Accelerate its Development

Oculis

The Swiss-Icelandic ophthalmology company Oculis, based in Zug with its operational headquarters in Lausanne, has completed an oversubscribed capital increase of $110 million. This is its second fundraising round exceeding $100 million in less than a year, following the one in February. Net proceeds from the financing will be used to advance and accelerate the…

Read More